EID Parry’s Q4 profit jumped 30% year-on-year to ₹287 crore, thanks to strong sales growth across key business segments. The company’s profit before tax (PBT) surged even more sharply—up 92.15% to ₹734.54 crore in the quarter ended March 31, 2025.
Earnings before interest, tax, depreciation, and amortization (EBITDA), excluding a one-time exceptional item of ₹347 crore, grew 8% to ₹626 crore compared to the same period last year.
What does this mean for the average person? Simply put, EID Parry is showing resilience and steady growth despite challenges in some segments.
This could boost investor confidence and reflect positively on the sugar and farm inputs sectors, which touch the everyday lives of farmers and consumers.
Digging deeper into the numbers, EID Parry’s sugar business revenue rose by nearly 7% to ₹1,372.89 crore. The distillery business did even better, growing almost 20% to ₹268.19 crore.
Consumer products surged 45% to ₹195.32 crore, while crop protection and nutrient businesses also posted healthy gains of 23.8% and 28.2%, respectively.
However, not all segments danced to the same tune. Nutraceuticals revenue dipped 15%, and cogeneration income dropped by a quarter.
Also Read ITC Shares Sink 3% as BAT Offloads ₹13,300 Cr Stake
Standalone results tell a slightly different story: a net loss of ₹231.7 crore this quarter, against a net profit of ₹80.27 crore a year earlier. Yet, standalone net sales were up 13.5%, signaling that the top line is on the rise even if profits are mixed.
Among segments, farm inputs continue to shine, with profit before interest and tax (PBIT) climbing 26% to ₹398 crore.
Meanwhile, sugar division profitability took a hit, with PBIT falling sharply from ₹164 crore to ₹26 crore. The nutraceuticals division remained modestly profitable but declined, and the consumer products group widened its loss.
The company’s subsidiary, Coromandel International, declared a final dividend of ₹6 per share and a special dividend of ₹3 per share. EID Parry expects to receive nearly ₹149 crore from this payout.
This dividend boost will surely bring some cheer to shareholders.
Also Read MedPlus Health Surges to 52-Week High as Q4 Profit Soars 54% YoY
Adding to the company’s growth plans, the board approved an investment of up to ₹350 crore in its wholly owned subsidiary Parry Sugars Refinery India (PSRIPL). The investment aims to reduce debt and strengthen the subsidiary’s balance sheet—good news for long-term stability.
EID Parry operates primarily in sugar, nutraceuticals, ethanol, and farm inputs, including biopesticides, largely through Coromandel International. This diversified portfolio helps balance the ups and downs seen across its segments.
In the stock market, EID Parry’s shares gained nearly 1% to ₹990.45 on the BSE following the results. The numbers suggest that while the sugar segment struggles, overall business strength and smart investments keep the company on a promising path.
Also Read Belrise Industries Shares Open Strong at ₹100: Buy, Sell or Just Hold Tight?
